How a molecule made by a plant reaches a person, what happens when it arrives, and where the honest account runs out.
~14 min read
A plant does not make its oil for you. What is in your bottles was made in glands on a leaf, in the rind of a fruit or in the resin of a wounded trunk, for the plant’s own purposes. So the question a healer answers first is why a compound built for that should affect you at all — because being natural buys a molecule nothing. Cellulose is natural and you cannot digest it.
Something narrower has to be true: a molecule has to get in, meet something that recognises it, and arrive in a mixture that may matter as much as the molecule. What essential oils are and distillation cover the bottle; this is what happens when it is opened.
Photograph to come
A peppermint or oregano leaf surface photographed at high magnification, lit so the glandular trichomes are unmistakable — the small round structures sitting on the surface, each holding oil under a thin cuticle, some intact and at least one visibly ruptured. Close, textural, scientific rather than styled. No bottle, no hands, no product.
Aromatic, topical, internal. Treat those words as what they physically are: three doors into a body, with different speeds, destinations and amounts arriving. The practical side belongs to how to use oils.
| Route | What physically happens | How fast | How much arrives |
|---|---|---|---|
| Aromatic | Molecules leave the liquid into the air and are drawn in on a breath, meeting the smell patch high in the nose and the lining of the lungs. | Seconds | A very small share — smell needs almost nothing to register. |
| Topical | A drop either evaporates or dissolves into the fatty mortar between the outer layer’s dead cells and works down to the vessels beneath. | Minutes | A fraction of the drop. Most of it leaves as vapour first. |
| Internal — only if the label on your bottle says so | The drop crosses the gut wall into the vein to the liver, and is altered there before the rest of the body sees it. | Tens of minutes | The largest share, which is why the dose is one drop and labelling decides whether it is a route at all. |
Speed is set by the distance to the first thing that can respond, and how much you use is not how much arrives. Which makes “what does this oil do” incomplete. The complete question: which constituent, by which route, at what dose?
Diagram to come
One simplified body with three routes traced from the same bottle, drawn at visibly different line weights so a reader can tell at a glance which delivers most material. Route one, aromatic: molecules leaving an open bottle into air, a breath drawn in, then splitting into two destinations — a short bold branch to the smell patch high in the nose and on to the olfactory bulb, and a thinner branch continuing down the airway to a single alveolus and across into blood. Route two, topical: a drop on a forearm with a cutaway of the outer skin layer showing a winding path between flattened dead cells down to the vessels beneath, plus a large arrow leaving the skin surface as vapour to show that most of a neat drop never goes in. Route three, internal: a drop swallowed, crossing the gut wall into the vein running to the liver, drawn arriving at the liver FIRST and leaving it visibly altered before reaching the rest of the body. A small clock beside each route reading seconds, minutes, tens of minutes. No condition, no symptom and no outcome anywhere in the drawing.
High in the nasal cavity, above the airflow of quiet breathing, sits a patch of tissue a few square centimetres across under a film of mucus. A molecule must be volatile enough to be airborne and soluble enough to dissolve into that film before anything happens. Embedded in it are sensory neurons carrying one each of roughly four hundred receptor types. One of the right shape settles in, and that neuron fires.
Their fibres pass through a perforated shelf of bone and end in the olfactory bulb. Sight, sound, touch and taste report first to the thalamus, a relay in the middle of the brain. Smell does not: projections leave the bulb straight into the limbic structures, the ones handling emotional significance and memory. That is the layout of a cranial nerve, described long before anybody sold a diffuser; the nervous system has it in full.
What the anatomy licenses, and what it does not
It licenses this: a molecule from a plant reaches a structure inside your head by a short path, in seconds, skipping the relay every other sense passes through. It licenses nothing about what a particular aroma does after arrival — a second question, answered molecule by molecule.
The route runs on almost nothing. Smell registers far below what any kitchen instrument could detect, which is why one drop scents a room and more oil in a diffuser is not more effect. Olfactory receptors report change rather than steady state, so a continuous aroma stops being perceived within minutes while the room carries on loading; an intermittent setting gives a stronger impression from less oil. Smell is also not the only thing on a breath — the same air reaches the alveoli, fifty to eighty square metres of surface behind a wall two to six tenths of a micrometre thick, which small volatile molecules cross readily into blood. The trigeminal nerve carries the cool and pungent sensations that are not smell, where peppermint picks up.
The outer layer of skin is dead flattened cells packed in a continuous fatty mortar, and that mortar is the filter: a molecule must dissolve into fat, thread down between the cells, and come out into the watery tissue below. The integumentary system has that anatomy in full.
A neat drop on warm skin is largely gone within minutes — most of it leaves as vapour. A carrier oil is not volatile. It holds the constituents against the surface and spreads the same drops over a larger area, so concentration at any one point falls. Irritation falls with concentration; total crossing does not, and can be higher than from the neat drop. Diluting is not weakening — it is the difference between a drop that evaporates and one that stays put long enough to go somewhere.
Two properties predict what crosses: size and polarity. Size first. Chemists measure molecular mass in daltons, and skin research works to a rough ceiling around five hundred, above which almost nothing crosses intact skin unaided. Almost every constituent in your bottles sits between about 130 and 220. Limonene, 60–75% of lemon oil, is 136. Linalool, 20–47% of lavender, is 154; linalyl acetate, 25–45% of the same oil, is 196. Menthol, 30–50% of peppermint, is 156. Beta-caryophyllene, 45–65% of copaiba, is 204. These are not borderline cases — they are small molecules by any standard, and that is what the fraction is.
Polarity is the other half. A charged molecule will not enter a fatty layer at all, which is why mineral salts sit on the surface, and why water — tiny at 18 daltons, but polar — barely crosses. You do not swell up in the bath. A pure hydrocarbon such as limonene carries no water-friendly group and slips in readily. One carrying an alcohol group, the -OH on linalool or on menthol, is a little more water-tolerant, which changes how fast it goes and how long it lingers. Functional groups is where that stops being a fact to remember and becomes a way of predicting.
The same two properties decide whether a molecule can cross a cell membrane, because a membrane is also a fatty layer with water on both sides. Small, uncharged and fat-soluble describes what passes a membrane without a channel, a carrier or a pump — and it also describes the essential-oil fraction of a plant. Steam distillation collects precisely the molecules small and volatile enough to leave with the steam, and those are the same molecules that cross a lipid barrier. One rule, met twice: once at the skin, once at every cell. The body as systems sets out the membrane version in full.
Four ordinary things raise the rate of crossing, all met in a normal day. Heat opens the vessels underneath and keeps the gradient steep. Water swells the outer cells and loosens the mortar, so skin straight out of a bath is more permeable than dry skin. Occlusion — a plaster, tight clothing, a thick balm laid over the top — does the same and can multiply what crosses several times over. And broken skin has no barrier at all, which is the reason nothing goes on it. Anything that raises the rate raises the dose, and dose is the thing dilution exists to control.
Safety holds the dilution figures. Two rules belong here too. Some oils need heavier dilution than the rest — oregano, thyme, cinnamon, clove and cassia, and peppermint on a child. And the expressed citrus oils, lemon, lime, grapefruit, bergamot and wild orange, carry a separate rule that has nothing to do with dose: after applying them to skin, avoid direct sunlight and UV for up to twelve hours.
A molecule that has crossed a barrier has not thereby done anything. What happens after arrival is a separate question, and its answer is shape.
A receptor is a protein with a pocket in it. It has no preferences, only a shape, and when something of a matching shape settles into that pocket the protein bends — the bend is the signal. That is the mechanism underneath nearly every message your body sends itself: hormones, neurotransmitters, immune signals, all a shape meeting a pocket. A molecule shaped by nature to do one job in a plant can happen to carry a region that fits a site in an animal, and that coincidence of geometry — not any intention — is why plant chemistry touches human physiology at all.
Menthol and the cold receptor
Sensory nerve endings in skin carry a channel that opens when the tissue around it drops below roughly 26 °C. Menthol fits that channel and holds it open at ordinary skin temperature, so the nerve sends the signal it would send in cold water while a thermometer reads unchanged — a sensation produced by a shape, with no temperature change behind it.
Beta-caryophyllene and CB2
A sesquiterpene making up 45–65% of copaiba and 8–46% of black pepper, and one of very few essential-oil constituents shown to dock directly into a named human receptor. The endocannabinoid system follows it in full.
Diagram to come
Two panels making one argument. Left panel: a receptor pocket in cross-section with three molecules approaching it — one drawn as coming from a gland in the body, one from a leaf, one from a laboratory flask — all three drawn at the same size, weight and colour so the image cannot be read as "the plant one is best". One of them settles into the pocket, the protein visibly bends, and a signal leaves the far side. Right panel: the overlap argument as two circles of very different size, a small set labelled as the shapes a receptor pocket accepts and a very large set labelled as the shapes plant chemistry produces, with the intersection shaded and two molecules drawn sitting inside it. No body, no bottle, no outcome and no condition anywhere.
The objection to everything above is a good one and deserves stating at full strength. A plant has no reason to make anything that fits a receptor in an animal that has never eaten it and never will. So why should any plant compound fit anything of yours? If the fits were common, that would be suspicious. If they were impossible, this platform would have nothing to teach.
The resolution is that the plant does not have to intend it. A receptor pocket is a small volume with a particular arrangement of chemical groups around its walls, and the number of distinct molecular shapes that will settle into such a pocket is limited. The number of shapes plant chemistry produces is not. A single family of plants builds thousands of related terpenes from one five-carbon unit repeated, folded and decorated in different arrangements — that is the whole subject of terpenes. Two sets, one small and one enormous, drawn from the same universe of possible shapes, will overlap. The overlaps are neither designed nor miraculous. They are what happens when a few shapes are recognised and a great many shapes are made.
Three qualifications keep this honest, and they are the ones usually left out. A fit is not necessarily a tight fit: chemists call the strength of the hold affinity, and most plant compounds bind far more weakly than the body’s own messengers do, which is one straightforward reason effects are modest rather than dramatic. A fit somewhere is not a fit everywhere: the same molecule at the same receptor in two different tissues produces two different outcomes, because what follows the bend depends entirely on what that cell does for a living. And the great majority of constituents in the great majority of oils have no described receptor at all. The two named above are famous precisely because they are exceptions — the rare cases where a mechanism has been pinned to a named protein. For most of what is in a bottle, nobody knows, and saying so is not a weakness in the account. It is the account.
A bottle is not a single molecule. An oil is a mixture — dozens to hundreds of compounds in ratios nobody chose — and it can behave differently from its main constituent alone. That question is open, and where the loudest claims live.
Researchers at Roseman University College of Pharmacy independently purchased doTERRA essential oils and tested them without doTERRA’s knowledge. A team led by Drs Tim Le and Jeffrey Talbot ran them through several laboratory models and reported that each oil had quantifiable and reproducible biological activity. When they isolated the constituents and tried to reproduce those measurements from the purified parts, they could not — not even at the concentration a constituent held in the whole oil. They named it the Oil Effect.
The framing matters more than the result. All of it was done on cells in laboratory models; nothing was measured in a person. The first phase carried weight because the oils were bought anonymously. doTERRA then awarded $128,000 in grant funding to advance the work, and later testing using nanofluidic proteomics reported that the oils switched on cell signalling pathways strongly while other suppliers’ oils did much less. That the later phase was company-funded is no reason to discard it, but it belongs beside the finding.
Diagram to come
The Roseman experiment drawn as an experiment rather than as a claim. Left column: a whole oil applied to a dish of cells, with a measured readout drawn as a clear signal trace. Right column: the same oil separated into its named constituents shown as a row of labelled vials, recombined at matching concentrations, applied to an identical dish, and a readout trace that is visibly flatter and different in shape. Beneath the vials, a row of small unlabelled dots drawn at the same weight as the named constituents, standing for the dozens of minor compounds that were never isolated, so a reader can see what was left out of the reconstruction. Across the bottom of both columns, one bracket carrying the honest caption that both dishes are dishes. No body, no person, no outcome.
“We found that each of the doTERRA oils had quantifiable and reproducible biological activity. To our surprise, we could not replicate the biological effects by breaking down the oil and administering its purified constituents. In a sense, we tried to synthetically build identical essential oils, with no success.” — Dr Jeffrey Talbot, Roseman University College of Pharmacy, on the cell-model work.
Established
An oil is a mixture, and the named constituents are a partial description of it. A gas chromatograph routinely resolves far more peaks than any label lists, and those minor compounds are real chemistry rather than padding. That mixtures behave differently from their isolated components is ordinary and well documented across plant chemistry — in laboratory models, which is where it has been looked at.
Established, and usually missed
For the aromatic route the whole-oil difference is not mysterious at all. Smell is a pattern across hundreds of receptor types at once, so a mixture and its main constituent do not smell like the same thing — and where a route works through perception, a different pattern is a different input. Lavender is instantly recognisable and almost impossible to describe for exactly that reason.
Suggestive
Several mechanisms could explain a mixture outperforming its parts, and each is plausible rather than demonstrated for oils in people: a minor constituent changing how readily the major one partitions into a membrane, so that more of it arrives; two constituents competing for the same enzyme, so one is broken down more slowly; several weak actions at different sites adding up to one measurable change. Plausible is not shown.
Marketing
That “synergy” means an oil can do more than its chemistry allows. That a laboratory finding about a mixture demonstrates anything about what happens inside a body. That a comparison between products in a dish establishes a brand’s superiority anywhere else. And that any of it supports a claim about a named condition, which none of it does and none of it was ever designed to.
One consequence follows, and it is why purity is a lesson of its own. If the character of an oil belongs to the whole mixture, then an oil extended with a cheaper oil, or topped up with a synthesised copy of its main compound, is a different mixture rather than a weaker version of the same one — which is why testing looks at more than the compounds a label names.
A healer who can say clearly what is not known is worth listening to about what is. Most published essential-oil research is in vitro — Latin for in glass. A compound and a culture of cells are put together in a dish at a concentration and contact time chosen by whoever ran the experiment, with nothing else present. That is legitimate work, and the furthest thing in the laboratory from a person: a dish holds a fixed concentration for hours, while a body dilutes a dose into some forty litres of water and steadily clears it.
Why a dish is not a person
In a dish a fixed concentration sits against the cells for hours, undisturbed. In a body a dose is diluted into some forty litres of water, spread unevenly between tissues, altered by the liver and steadily cleared — and many concentrations that produce effects in vitro are ones no route into a body would ever reach. That one comparison disposes of a large share of what circulates as evidence.
Animal studies are a step closer and still do not transfer cleanly. Species differ in the liver enzymes that break these molecules down, so the same dose becomes different amounts of different products. Rodent skin is considerably more permeable than human skin, so a topical result measured there is not comparable to one in a person. And doses are often set per kilogram far above anything anyone uses. Animal work can tell you a compound is biologically active in a mammal; it does not tell you the size, the reliability or sometimes even the direction of an effect in you.
Human trials exist and are the smallest part of the literature: few, small, short and frequently hard to interpret. Aroma is unusually difficult to test, because blinding it is close to impossible — a participant can smell which group they are in — and expectation is not merely noise here but part of the very mechanism under study, given where the olfactory route lands. Add that two bottles carrying the same botanical name can differ substantially in composition by growing region, season and harvest, and that there is rarely an agreed dose to test in the first place, and the picture is of a field that is young rather than one that is settled.
None of that dismisses the subject. The transport is not in doubt: these molecules are small, fat-soluble and uncharged, and they cross barriers — that is physics, measured directly. The olfactory anatomy is not in doubt, and particular receptor fits are not in doubt at the molecular level. What is uncertain is the step from “a molecule arrives and binds” to “an outcome in a person”. Hold both halves at once: the mechanism is real, and the effect sizes are modest and mostly unmeasured.
Four things follow, and they are the habits that separate a healer from a repeater.
All of this sits alongside professional medical care and does not replace it. Anything persistent, severe, or new and unexplained belongs with a practitioner who can examine you.
Keep oils away from eyes and inner ears, and out of reach of children. If you are pregnant, nursing, under medical care or taking medication, speak to your healthcare practitioner before use. Nothing here is intended to diagnose, treat, cure or prevent any disease.
Lesson 6 of 21 · Essential Oils